Plain-English translation of NCT06782971 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
COSMOS-Avatar is testing a new approach to treating acute myeloid leukemia (AML) — a serious blood cancer. The study uses cancer cells donated by patients to create laboratory models that help doctors find the best drug combinations for each person's cancer. The goal is to identify treatments that work better and cause fewer side effects than current options.
Many patients with AML cannot tolerate standard intensive chemotherapy, and when they do receive treatment, the cancer often comes back or stops responding. This medication works for some patients but doesn't always work well enough, and doctors need a better way to figure out which combinations of drugs will help individual patients the most.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would be asked to donate a sample of your cancer cells, which researchers would use to create a laboratory model of your specific disease. You would continue receiving your regular treatment with the medication as planned. Researchers would then test different drug combinations on your model to see which ones work best, helping to guide your care and future patients' treatments.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
Australia